Next Article in Journal
Equal Opportunities for Stroke Survivors’ Rehabilitation: A Study on the Validity of the Upper Extremity Fugl-Meyer Assessment Scale Translated and Adapted into Romanian
Previous Article in Journal
The Value of Targeting Complement Components in Asthma
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Knowledge about Cervical Cancer and Awareness of Human Papillomavirus (HPV) and HPV Vaccine among Female Students from Serbia

by
Nataša K. Rančić
1,*,
Milan B. Golubović
2,
Mirko V. Ilić
3,
Aleksanda S. Ignjatović
1,
Radomir M. Živadinović
1,
Saša N. Đenić
4,
Stefan D. Momčilović
5,
Biljana N. Kocić
1,
Zoran G. Milošević
1 and
Suzana A. Otašević
1
1
Faculty of Medicine Niš, University of Niš, 18 000 Niš, Serbia
2
Clinic of Pediatrics, Clinical Center Niš, 18 000 Niš, Serbia
3
Center for Control and Prevention of Diseases, Institute for Public Health Niš, 18 000 Niš, Serbia
4
Center for Radiology, Clinical Center Niš, 18 000 Niš, Serbia
5
Clinic for Reconstructive and Plastic Surgery, Clinical Center Niš, 18 000 Niš, Serbia
*
Author to whom correspondence should be addressed.
Medicina 2020, 56(8), 406; https://doi.org/10.3390/medicina56080406
Submission received: 15 July 2020 / Revised: 2 August 2020 / Accepted: 5 August 2020 / Published: 13 August 2020
(This article belongs to the Section Epidemiology & Public Health)

Abstract

:
Background and objectives: Persistent infection with carcinogenic human papillomavirus (HPV) is the leading cause of cervical cancer. The study explored students’ knowledge about cervical cancer and awareness of human papillomavirus and the HPV vaccine. Materials and Methods: A questionnaire-based survey was carried out among 1616 first-year female college students at the University of Niš. It examined socio-demographic characteristics, measured the score of knowledge about cervical cancer, assessed awareness regarding HPV and the HPV vaccine and inquired about the source of information about cervical cancer and HPV. Results: The average cervical cancer knowledge score was 16.35 ± 7.92 (min 0, max 30), with medical professional education, parents’ education level, place of residence and relationship status having significant effects on the score. The awareness about HPV and the HPV vaccine was low, with only 14.2% of students having heard about both HPV and its vaccine. The most commonly reported sources of information were the media, while the most competent one was organized health education. Conclusions: Health promotion campaigns and educational programs are necessary in order to reduce cervical cancer burden and should be directed particularly towards those who have demonstrated low cervical cancer knowledge and low awareness regarding HPV and its vaccine.

1. Introduction

Malignant disease rates have reached enormous proportions globally and are appropriately considered a modern age plague. Cervical cancer (CC) is the most common gynecological malignancy and has the fourth highest incidence and mortality rate among women worldwide, with about 570,000 cases and 311,000 deaths in 2018 [1]. This dreadful statistic is mostly the result of inefficiently organized health systems in developing and especially in underdeveloped countries. Accordingly, particularly affected by CC are sub-Saharan African and Southeast Asian countries, in which this disease represents the leading cause of cancer death ahead of breast and lung cancer [1].
In Europe, CC causes just over 61,000 new cases per year, which makes it the ninth most common cause of female cancer, and when it comes to cancer deaths, it is ranked 11th. However, it is ranked second in both incidence and mortality among females between 15 and 44 years of age [2]. This trend of reaching peak incidence at younger age, which has been consistantly observed during the past several decades [3], indicates that CC is an age-related disease, especially afflicting women of reproductive age.
This cancer has slow progression [4] and when diagnosed in the early stages it is highly treatable, with a 5-year relative survival rate of up to 92% [5]. Besides, it is the first cancer to have am identified agent essential for its development, human papillomavirus (HPV) infection. Back in the 1970s, zur Hausen suggested a possible association between HPV infection and cervical cancer [6], which was confirmed in the following decades [7]. More than 200 HPV types have been recognized and about 40 of them are sexually transmitted and capable of causing mucosal infection [8,9]. Among them, several types have been recognized as high risk according to their oncogenic potential, with types 16 and 18 being the most prevalent ones [8].
Findings from the first study of HPV infection prevalence in Serbian women [9] showed that nearly one third of HPV-positive women in Serbia had types HPV16/18, marked as the most aggressive high-risk genotypes of human papillomavirus HR-HPVs. According to the findings of Kovačević [10], the most prevalent HPV types in females of the Autonomous Province of Vojvodina, in Serbia, are: HPV 16; HPV 31, HPV 51; HPV 33; HPV 18; HPV 52; HPV 56; HPV 39; HPV 45; HPV 58; HPV 59 and HPV 35 and the most frequent HPV types are type 16 and type 31. The most prevalent HPV types of this region showed concordance with European isolates, but non-European variants were also found [10,11].
Viral DNA of these high-risk strains nowadays can be easily detected in exfoliated cervical cells using commercially available tests [12]. This HPV test represents a convenient, highly sensitive screening tool that is rapidly becoming a part of screening guidelines of many countries and has a tendency of becoming the main screening method [13]. Still, it has an important flaw and that is its lower specificity [12]. Apart from this, there is also the well-known Pap smear screening method. It is widely available, cheap and has good specificity for the detection of precancerous lesions with a proven impact on reducing CC prevalence and mortality rates [13]. Organized cervical cancer screening has been conducted in Serbia since 2012 and it covers women aged 25 to 69 years [14]. Alongside these secondary prevention methods, since 2006 there has also been a primary prevention option available—the HPV vaccine. It can be found in bi-, quadri- and nine-valent formulations [10] and the recommendation is that girls should be routinely vaccinated between the ages of 9 and 13 [15]. Although the Advisory Committee on Immunization Practices (ACIP) approved the vaccination of boys aged 9 to 26 in October 2011, it is currently only being implemented in the United States of America (USA), some Canadian provinces, Australia and New Zealand [16].
Recommendations for the use of prophylactic vaccines vary by continent and region and, in most countries, including Serbia, only women are currently vaccinated. It is generally recommended that children and young adults aged 9–26 should be vaccinated [11]. In Serbia, vaccination against HPV infection is not part of the mandatory immunization program [14,15,16,17]. HPV vaccination is recommended for children older than nine years before the first sexual intercourse, and primarily for children in the sixth grade of primary school (12 years of age). Active immunization is carried out with the required number of doses (two or three), depending on the type of vaccine and the age at which it is given [17].
Based on the obtained results on the prevalence of the oncogenic types of HPV in the region of the Autonomous Province of Vojvodina, it can be assumed that the introduction of prophylactic bi-valent and quadri-valent HPV vaccines will reduce by nearly 50% the infection caused by high-risk HPV types 16 and 18. The protective effect of the nine-valent vaccine could be close to 90%. The nine-valent vaccine does not contain HPV 35, 56 or 59 [11], so there is a need to develop an HPV vaccine that will be specific for these HPV types in the Serbian population.
As registered vaccines do not provide protection against all oncogenic HPV types and no vaccine is 100% effective, it is necessary to adhere to national recommendations for cervical cancer screening regardless of vaccine status [18].
In addition to chronic HPV infection, other risk factors play an important role in the development of CC as well. Among them, the most notorious are smoking, immunodeficiency, long term use of oral contraceptives, promiscuous behavior and having more than two pregnancies. A family history of CC and other descriptive characteristics, obesity and poor diet are also associated with CC [19,20,21,22].
Although in Serbia there is an organized CC screening program and the HPV vaccine is recommended and available for purchase, CC still remains one of the most prevalent malignancies. According to data from the last available national registry in 2015, it was the fourth most common cancer among women in Central Serbia [23]. In 2018, it was assessed that it causes about 1300 new cases and 550 deaths annually. In addition, Serbia has the highest age-standardized CC mortality rates when compared with other Southeast European countries [2].
The objective of the study was to evaluate knowledge about CC, as well as awareness of HPV and HPV vaccination among first-year female college students from Niš, Serbia. In addition, the sources of students’ information about the subjects were also analyzed. The idea was to identify potential target groups for the implementation of customized health promotion programs.

2. Material and Methods

2.1. Study Design

The study was designed as a cross-sectional survey conducted between December 2018 and March 2019. Participants were female, first-year college students at the University of Niš during a mandatory medical check-up. All subjects were informed that participation in the study was voluntary and that by completing the questionnaire the consent for publication was given. It was made clear that the data collected would remain anonymous. The approval for the study was obtained from the Ethics Committee of the Faculty of Medicine, Niš (number of decision: 01-10204-11/2012).
A total of 2008 questionnaires were distributed and 1616 fully completed, valid questionnaires were included in the study.

2.2. Questionnaire

Data were collected using a semi-structured questionnaire specially created for this investigation. It was a self-administered questionnaire with three distinct sections (Supplement File 1).
  • Section 1: The first section explored respondents’ socio-demographic characteristics, including age, type of faculty, mother’s and father’s education level, place of residence, type of secondary school completed and financial and relationship status. In addition, participants were asked if they ever had sexual intercourse and, if yes, how many sexual partners they had had.
  • Section 2: The second section consisted of 22 items divided into three subsections (CC knowledge, HPV awareness, HPV vaccination awareness). CC knowledge was evaluated by a composite score estimated using a total of 18 items regarding risk and protective factors, preventive measures and the outcome of CC. Participants had three possible response options regarding proposed factors (protective factor, risk factor and do not know) and correct answers were coded with either one or two points, deepening factor significance. As for the rest of the questions, the given options were “true”, “false” and “do not know” and correct answers were given two points. The total number of points represented the participant’s CC knowledge score (CC-KS), with higher scores meaning better knowledge. The maximum number of points was 30. All questions were based on data from the relevant literature and information provided by the American Cancer Society [14,15,16]. Awareness about HPV was determined based on whether or not participants had heard about HPV infection. The remaining three items were related to HPV vaccination. Subjects were asked to indicate if they have heard about the HPV vaccine. If the answer was positive, they then answered when the best time to get the HPV vaccine is and if the HPV vaccine is available in Serbia.
  • Section 3: The last part of the questionnaire inquired about the source of respondents’ knowledge about the subject. Thirteen multiple choice answers, from three categories of source (personal contact, organized health education (OHE) and media) were offered. The opportunity to declare not having any knowledge was also given.

2.3. Statistical Analysis

Data are presented as the mean and standard deviation (SD) or as frequencies and proportions. Comparison of the mean values between two groups was done using t-tests or Mann–Whitney tests depending on data distribution, while the mean values between the three groups were compared using either ANOVA or Kruskal–Wallis tests. The chi-squared test was used for the comparison of categorical variables. The p-value was set at p < 0.05 (two-tailed). All statistical analyses were performed using R software, version 3.0.3 [24].

3. Results

Overall, 1616 participants completed the whole questionnaire, meaning that the response rate was 80.5%. The average age of the study population was 19.13 ± 0.73 years (min 17, max 29), with the majority of the subjects coming from urban areas (75.7%). Their other socio-demographic characteristics are presented in Table 1.

3.1. Knowledge about CC

As described in the methodology, the knowledge about CC was evaluated using a composite score. It was established that the average score in our students was 16.35 ± 7.92 (min 0, max 30). Statistical analysis showed that medical students had significantly a higher knowledge score compared to other, non-medical students (p < 0.001). Pre-college education also significantly influenced participants’ scores (p < 0.001), with the highest score noted in students that previously attended medical high school, followed by those that attended grammar schools (Table 2). Furthermore, a significant difference in the score was established between participants from urban and rural areas (p = 0.01), with the former being better informed about CC. Mother’s and father’s level of education also influenced the CC knowledge of our subjects (p < 0.001 and p = 0.006, respectively). The knowledge was significantly higher in students whose mothers had middle (p = 0.002) and high (p < 0.001) education compared to those with low education. Likewise, having a father with high education meant having higher score (Table 2). The financial status of participants was significantly associated with knowledge score (p = 0.008). Thus, participants with high and middle incomes demonstrated higher scores (Table 2). Students in a relationship showed better knowledge than single students (p = 0.019). Hohd On the other hand, no significant difference was proven between women that had sexual experience and those who did not (Table 2). It is correct. Those who were in relationship were more aware both of HPV infection and CC.

3.2. HPV and HPV Vaccine Awareness

The total number of participants that had heard of HPV infection was 788 (48.8%), with a significantly higher percentage of medical students being aware of this infection (p < 0.001). Furthermore, knowledge of this infection differed significantly depending on the type of secondary education (p < 0.001). Thus, students that had finished medical high school had significantly higher knowledge compared to those from grammar school (p < 0.001) and non-medical high schools (p < 0.001). Finally, students that were in a relationship (p = 0.005) and that were sexually active (p = 0.001) knew about HPV infection significantly more often (Table 3).
When it comes to HPV vaccine, the overall awareness was quite low (21.3%), whereas an even lower percentage of students had heard of both HPV and its vaccine (14.2%). A statically significant difference was noted relative to mother’s education and relationship and sexual status. Students raised by highly educated mothers had heard of the HPV vaccine more often (compared to students whose mothers had low education, p = 0.028), just as the students that were in relationships (vs. single, p = 0.041) and that had had sexual intercourse (compared to those who had not had sexual intercourse, p = 0.001) (Table 3).
The other two questions about HPV vaccination were correctly answered by only a small number of subjects. Of those who declared that they were aware of HPV and the vaccine, only 37 knew when the best time to get the HPV vaccine is and 48 knew that it is available in Serbia. No difference between distinct demographic groups was established (Table 3).

3.3. Source of Information

The media was listed as the dominant source of information about the investigated topics by 1011 of the examined students. The other two categories, organized health education (OHE) and personal contact, were reported as sources by 866 and 538 students, respectively. Two hundred and fifty-five subjects declared having no knowledge about the investigated topics.
The knowledge score was significantly higher in subjects that received information from any of the three source categories compared to subjects who denied receiving information from those particular categories (Table 4). A similar relationship is noted between information sources and HPV awareness. Among the students who knew about HPV, significantly more reported acquiring information through each of the source categories (vs. not acquiring information through those sources). Finally, OHE was the only information source category associated with a significantly higher number of subjects that had heard about the HPV vaccine (p < 0.001), that knew when it should be administered (p = 0.039) and that it is available in Serbia (p = 0.029).
The complete statistical analysis regarding the sources of information among our participants and their relationship with CC-KS, HPV and the HPV vaccine awareness is shown in Table 4.

4. Discussion

“An ounce of prevention is worth a pound of cure,” an old quote popularized by Benjamin Franklin (1735), makes a lot of sense in medicine [25]. Prevention is especially important in oncology, since cancer is one of the biggest public health issues in the modern world. Paradoxically, despite being highly suitable for thriving preventive programs, CC still represents the most common gynecological cancer worldwide [1]. Therefore, public education is needed for a better understanding of CC, its risk factors and for better disease prevention. Such education programs are only efficient when planned with carefully selected target groups. Aiming to define possible groups for these education programs in Serbia, in this article, we analyzed the knowledge and awareness of first-year female students about CC and HPV.
Our students demonstrated decent knowledge about CC, with the mean score being more than half of the total possible score. However, in a study done in Serbia’s capital, Belgrade, a considerable portion of women had insufficient knowledge about CC, especially those who did not participate in mass screening [26]. This discrepancy can be explained by differences in the study population, since our research included only college students, the future intellectual elite of the state. Furthermore, a good share of our participants had affiliation with the medical profession, which greatly contributed to a higher CC knowledge level. In that manner, we proved that subjects involved in medical studies or those that attended medical high school had the highest knowledge about CC. Other authors also confirmed that medical students are highly educated on this matter [27,28], which is understandable and very commendable, as they represent the leaders of further education of the general public about CC. In accordance with the previous interpretation, the results of another Serbian study showed that both students of a secondary medical school and midwives who had finished at that same school had significantly better knowledge than patients [29]. Apart from education, we also identified good financial status, living in urban areas and having parents with higher education as factors that contribute to better knowledge about CC. This means that higher socio-economic status is associated with a better health standard and can explain the fact that the highest prevalence of CC is seen in underdeveloped countries [1]. However, data from relevant studies are inconsistent regarding this matter, occasionally showing low knowledge about CC even in people from developed countries. For example, in other Balkan countries, the situation regarding CC and HPV knowledge is generally quite poor. In Romania, even though the majority of interviewed women had heard of HPV, the level of knowledge was low, especially about risk factors for infection [30]. Likewise, Greek adolescents were also insufficiently informed about risk factors and protection methods against CC [31]. A similar situation is also recorded in Hungary and Slovenia [32,33]. The inconsistency of the results from different studies was also noted regarding the association between relationship status and knowledge about CC. While in our study, students in relationship had a higher CC-KS, there are other studies in which being single was associated with knowledge about CC screening [34].
Despite relatively good knowledge about CC in the investigated population, HPV awareness was quite low. We established that a bit less than 50% of the investigated students had heard of HPV infection. Research performed in Slovenia [33] that included women of a wide range of ages and research that included adolescents from Greece [31] also noted low awareness of HPV. On the other hand, studies in the UK [35] and in neighboring Romania [30] showed that between two thirds and three quarters of questioned women had heard about HPV. Such a result was also recorded in our study among subjects that finished medical high school and those attending a medical faculty. Furthermore, these participants had significantly more chance of knowing about HPV, just as other studies established [36]. In addition, in our study, females in relationships and the ones that had sexual experience were more likely to have heard about HPV. This is encouraging since it implies that the subjects who enter into a relationship at least have basic awareness about HPV. Research completed in Germany also found that women that had had sexual intercourse at least once had more often heard of HPV [37].
A significant part of our study was also an investigation of HPV vaccination awareness. This topic was especially important, as CC prevalence in Serbia is very high [22,23]. Unfortunately, the obtained results are disappointing. Although 10 years have passed since the first shot was administered in Serbia, only one fifth of the students knew about the existence of the HPV vaccine and only 14.2% knew about both HPV and its vaccine. Even worse are the findings that, among those who were aware of the vaccine’s existence, only a few knew when it should be administered and that it is available in Serbia. These findings suggest that awareness about the prevention of CC, as an important public health issue, is still at a very low level, which can and should be raised by educating the populace. Another important element in the promotion of CC prevention is introducing the HPV vaccine into the National Immunization Program (NIP). Unfortunately, the HPV vaccine, although recommended, is not yet integrated in the Serbian NIP. On the other hand, this was done years ago in most EU countries, so their good perception about CC prevention is not surprising. In Italy, one of the world’s most developed countries, a remarkably high percentage of adolescents that know about HPV vaccine is observed [38]. Likewise, Serbia’s neighbors, Romania [30] and Hungary [32], as well as nearby Greece [31], also register good awareness of the HPV vaccine, despite the previously mentioned low knowledge. All these countries are in the EU and have included the vaccine in their NIPs, indicating its importance. On the other hand, data from Ukraine, an underdeveloped country that had not introduced the HPV vaccine in its NIP yet, show relatively low awareness of the vaccine among second-year medical students, but still a bit better than among our participants [39]. There were a small number of female adolescents that received the HPV vaccine, after a gynecologist’s recommendation. We do not have the data about vaccinated persons yet and we do not know the exact number of vaccinated persons.
Finally, we investigated the source of participants’ awareness and knowledge. The most frequently chosen source was the media with, 1011 students answering that this source contributed to their knowledge on the subject. Likewise, in another Serbian study, participating females identified the media as the main source of information about CC risk factors [40]. This is a substantial change from previously reported results that the media is a “poor source of comprehensive information on cervical cancer” [41]. Two separate pieces of research from Hungary and Slovenia also found that the media, namely the internet and magazines, to be dominant sources of information about this topic [32,33,42]. This confirms that the media has a great impact on public opinion and thus can be a powerful tool for increasing the awareness of CC. This source was also the most commonly selected among students that had heard about HPV, just as it was in an American study that also included young women [43]. Like so, those who selected the media as source of information had a significantly greater chance of knowing about HPV. In addition, a statistically significant difference in the CC-KS was established between participants who had been informed through the media and those who had not. Unfortunately, the knowledge score was more than one point lower than the score of participants who chose OHE or personal contact as a source. Such a result indicates that, although information from the media is important, it often does not have enough credibility and can even, if not critically assessed, produce counter effects and mislead the audience. Therefore, the accuracy of the information is crucial. Furthermore, the finding that there is no significant difference in HPV vaccination awareness between those who did and did not select the media as a source indicates that future media campaigns should be especially focused on this topic. Messages about HPV infection and HPV vaccination and its importance for the prevention of CC conveyed through media—to parents, providers, policymakers and the general public—may contribute to a rise in vaccination coverage. Regarding the competence of the source, according to the results of this study, OHE is the most efficient one, with the CC-KS being the highest in the participants who picked it. Besides, OHE significantly affected the awareness of HPV and was the only source that was associated with a significant likelihood of participants having knowledge about the HPV vaccine. While this is an expected result, it is more than welcome since it shows that OHE represents a trustworthy source, which should have a dominant role in educational programs. Other surveys also showed that physicians are the most desirable source of information, which is highly positive and means patients also recognize OHE as a qualified and authoritative source [44,45]. The third possible way of gaining information about CC was interpersonal communication with friends or family, which in our survey produced paradoxical results. Students that acquired knowledge through this source had a significantly higher CC-KS. On the other hand, a significantly smaller number of subjects that knew about HPV marked friends or family as an information source, while having knowledge about the vaccine was not associated with this source. Accordingly, although obtaining information from family or friends is easy, convenient and often the most common source of the subjects’ knowledge [45] our data suggest that it should not have the main role in education.

5. Conclusions

The present study revealed sufficient knowledge about CC in the examined population, but awareness about HPV infection was rather low. The situation about HPV vaccine awareness was even more disappointing, since only 14.2% had heard of both HPV and the HPV vaccine. Moreover, only a negligible number of students had knowledge about the best time to get the HPV vaccine and that the vaccine is available in Serbia. Since the highest score of knowledge about CC was determined in the group of students who denoted organized health education as a source of information, this established scenario should serve as a guide for the development of high-quality education programs directed particularly towards raising awareness about CC prevention and the importance of HPV vaccination. It can be recommended that a special focus should be on students whose commitments in education are not related to health sciences. Furthermore, in accordance with the result that the media was the most common source of information, these campaigns should be conducted using exactly this information source. However, steps must be taken in order to increase its reliability, thus making the media a powerful instrument through which correct information could be spread to general public. In addition to such well-targeted health promotion campaigns, an official national strategy is also necessary with the goal to introduce the HPV vaccine in the NIP, with monitoring and real support from authorities. Only by achieving these goals can the CC burden be reduced.

Supplementary Materials

The following are available online at https://www.mdpi.com/1648-9144/56/8/406/s1, File 1: Example of the questionnaire.

Author Contributions

N.K.R.—Study design, wrote the manuscript, acted as the correspondent author, M.B.G.—Software, did the internal revision of the whole manuscript, A.S.I.—Did statistical analysis, M.V.I.—Investigation, made the database, R.M.Ž.—Critically evaluated the text of the manuscript, S.N.Đ.—Checked the reference list, S.D.M.—Methodology, Z.G.M.—Revised results of statistical analysis, B.N.K.—Supervision of the research and revised the manuscript before final approval to submit, S.A.O.—Coordinated the research, revised the manuscript and gave final approval of the manuscript version to submit. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Conflicts of Interest

The authors declare no conflict of interest.

Abbreviations

CCCervical cancer
CC-KSCervical cancer knowledge score
HPVHuman papillomavirus
OHEOrganized health education
SDStandard deviation

References

  1. Bray, F.; Ferlay, J.; Soerjomataram, I.; Bray, F.; Ferlay, J.; Soerjomataram, I.; Siegel, L.R.; Torre, A.L.; Jemal, A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2018, 68, 394–424. [Google Scholar] [CrossRef] [Green Version]
  2. Bruni, L.; Albero, G.; Serrano, B.; Mena, M.; Gómez, D.; Muñoz, J.; Bosch, F.X.; de Sanjosé, S. Human Papillomavirus and Related Diseases in Europe. Summary Report 17 June 2019; ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre): Barcelona, Spain, December 2019. [Google Scholar]
  3. Seppä, K.; Pitkäniemi, J.; Malila, N.; Hakama, M. Age-related incidence of cervical cancer supports two aetiological components: A population-based register study. BJOG 2016, 123, 772–778. [Google Scholar] [CrossRef] [Green Version]
  4. Burd, E.M. Human papillomavirus and cervical cancer. Clin. Microbiol. Rev. 2003, 16, 1–17. [Google Scholar] [CrossRef] [Green Version]
  5. Siegel, R.L.; Miller, K.D.; Jemal, A. Cancer statistics 2019. CA Cancer J. Clin. 2019, 69, 7–34. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  6. Walboomers, J.M.; Jacobs, M.V.; Manos, M.M.; Bosch, X.F.; Kummer, A.J.; Shah, V.K.; Snijders, J.P.; Peto, J.; Meijer, C.J.; Muñoz, N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 1999, 189, 12–19. [Google Scholar] [CrossRef]
  7. zur Hausen, H. Human papillomaviruses and their possible role in squamous cell carcinomas. Curr. Top. Microbiol. Immunol. 1977, 78, 1–30. [Google Scholar] [PubMed]
  8. Muñoz, N.; Bosch, F.X.; de Sanjosé, S.; Herrero, R.; Castellsagué, X.; Shah, V.K.; Peter, J.F.; Snijders, F.J.P.; Chris, J.L.M.; Meijer, M.L.J.C. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med. 2003, 348, 518–527. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  9. International Human Papillomavirus Reference Center. Human Reference Clones, Stockholm: Karolinska Institutet. Available online: https://ki.se/en/labmed/international-hpv-reference-center (accessed on 15 December 2019).
  10. Malisic, E.; Brotto, K.; Krivokuca, A.; Cavic, M.; Jankovic, R. Overall human papilloma virus and types 16/18 prevalence in women with normal cervical cytology in Serbia: Is it time for human papilloma virus testing and/or vaccination? JBUON 2014, 19, 973–979. [Google Scholar]
  11. Kovačević, G. Typing of Human Papilloma Virus (HPV) and Molecular Variants of Identified Types. Ph.D. Thesis, Faculty of Sciences, Department of Biology and Ecology, University of Novi Sad, Novi Sad, Serbia, 2016. [Google Scholar]
  12. Kovacevic, G.; Milosevic, V.; Knezevic, P.; Knezevic, A.; Knezevic, I.; Radovanov, J.; Nikolic, N.; Patic, A.; Petrovic, V.; Cvjetkovic, I.H.; et al. Prevalence of oncogenic human papillomavirus and genetic diversity in the L1 gene of HPV16 HPV 18 HPV31 and HPV33 found in women from Vojvodina Province Serbia. Biologicals 2019, 58, 57–63. [Google Scholar] [CrossRef]
  13. Castle, P.; Feldman, S.; Perkins, R.B. The Next Generation of Cervical Cancer Screening: Should Guidelines Focus on Best Practices for the Future or Current Screening Capacity? J. Low. Genit. Tract Dis. 2018, 22, 91–96. [Google Scholar] [CrossRef] [Green Version]
  14. Chrysostomou, A.C.; Stylianou, D.C.; Constantinidou, A.; Kostrikis, G.L. Cervical Cancer Screening Programs in Europe: The Transition Towards HPV Vaccination and Population-Based HPV Testing. Viruses 2018, 10, 729. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  15. Centers for Disease Control and Prevention (CDC). Recommendations on the use of quadrivalent human papillomavirus vaccine in males—Advisory Committee on Immunizations Practices (ACIP), 2011. MMWR Morb. Mortal. Wkly. Rep. 2011, 60, 1705–1708. [Google Scholar]
  16. Koliopoulos, G.; Nyaga, V.N.; Santesso, N.; Bryant, A.; Martin-Hirsch, P.P.L.; Mustafa, R.A.; Schünemann, H.; Paraskevaidis, E.; Arbyn, M. Cytology versus HPV testing for cervical cancer screening in the general population. Cochrane Database Syst. Rev. 2017, 8, CD008587. [Google Scholar] [CrossRef] [PubMed]
  17. Ministry of Health of RS. The Rulebook on the Program of Mandatory and Recommended Immunization against Certain Infectious Diseases. Official Gazette of RS, 6 May 2020. [Google Scholar]
  18. National Guide of Essential Clinical Practice; Ministry of Health of the Republic of Serbia: Belgrade, Serbia, 2012.
  19. Peto, J.; Gilham, C.; Fletcher, O.; Matthews, E.F. The cervical cancer epidemic that screening has prevented in the UK. Lancet 2004, 364, 249–256. [Google Scholar] [CrossRef]
  20. World Health Organization. Comprehensive Cervical Cancer Control: A Guide to Essential Practice, 2nd ed.; World Health Organization: Geneva, Switzerland, 2014.
  21. American Cancer Society. Risk Factors for Cervical Cancer. Available online: https://www.cancer.org/cancer/cervical-cancer/causes-risks-prevention/risk-factors.html (accessed on 15 December 2019).
  22. Lee, J.K.; So, K.A.; Piyathilake, C.J.; Kim, M.K. Mild obesity, physical activity, calorie intake, and the risks of cervical intraepithelial neoplasia and cervical cancer. PLoS ONE 2013, 8, e66555. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  23. Institute of Public Health of Serbia. Cancer Registry of Central Serbia-Cancer Incidence and Mortality in Central Serbia, 2015; Report No. 17; Institute of Public Health of Serbia: Belgrade, Serbia, 2017.
  24. R Core Team R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing: Vienna, Austria. Available online: http://www.R-project.org/ (accessed on 15 February 2020).
  25. Franklin, B. On Protection of Towns from Fire. The Pennsylvania Gazette. Available online: https://founders.archives.gov/documents/Franklin/01-02-02-0002#BNFN-01-02-02-0002-fn-0001 (accessed on 27 December 2019).
  26. Jovanovic, V.; Jovanovic, A.M.; Kocic, S.; MVasiljevic, M.; Krasic, V. Knowledge about cervical cancer, Pap test, and barriers to women’s participation in screening in Belgrade, Serbia. Eur. J. Gynaecol. Oncol. 2017, 38, 69–75. [Google Scholar]
  27. Yam, P.W.A.; Lam, P.L.; Chan, T.K.; Chau, W.K.; Hsu, L.M.; Lim, M.Y.; Lo, H.C.; Siu, L.; Tang, F.H.; Tong, M.J.M.A.; et al. A Cross Sectional Study on Knowledge, Attitude and Practice related to Human Papillomavirus Vaccination for Cervical Cancer Prevention between Medical and Non-Medical Students in Hong Kong. Asian Pac. J. Cancer Prev. 2017, 18, 1689–1695. [Google Scholar]
  28. Monteiro, D.L.M.; Brollo, L.C.S.; Souza, T.P.; dos Santos, P.R.J.; Santos, R.G.; Correa, T.; da Costa, T.J.; de Oliveira, P.A.M.; Trajano, B.J.A. Knowledge on the HPV vaccine among university students. Rev. Inst. Med. Trop. Sao Paulo. 2018, 60, e46. [Google Scholar] [CrossRef]
  29. Antic, L.G.; Djikanovic, B.S.; Antic, D.Z.; Aleksopulos, H.G.; Trajkovic, G.Z. Differences in the level of knowledge on cervical cancer among health care students, midwives and patients in Serbia. Asian Pac. J. Cancer Prev. 2014, 15, 3011–3015. [Google Scholar] [CrossRef] [Green Version]
  30. Grigore, M.; Teleman, S.I.; Pristavu, A.; Matei, M. Awareness and knowledge about hpv and hpv vaccine among romanian women. J. Cancer Educ. 2018, 33, 154–159. [Google Scholar] [CrossRef]
  31. Vaidakis, D.; Moustaki, I.; Zervas, I.; Barbouni, A.; Merakou, K.; Chrysi, S.M.; Creatsa, G.; Panoskaltsis, T. Knowledge of Greek adolescents on human papilloma virus (HPV) and vaccination: A national epidemiologic study. Medicine (Baltimore) 2017, 96, e5287. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  32. Balla, B.C.; Terebessy, A.; Tóth, E.; Balázs, P. Young hungarian students’ knowledge about HPV and their attitude toward HPV vaccination. Vaccines 2016, 5, 1. [Google Scholar] [CrossRef] [PubMed]
  33. Vrscaj, M.U.; Vakselj, A.; Strzinar, V.; Bebar, S.; Baskovic, M.; Fras, P.A.; Djurisic, A. Knowledge about and attitudes to Pap smears, cervical cancer and human papillomavirus among women in Slovenia. Eur. J. Gynaecol. Oncol. 2008, 29, 148–153. [Google Scholar] [PubMed]
  34. Al-Naggar, R.A.; Low, W.Y.; Isa, Z.M. Knowledge and barriers towards cervical cancer screening among young women in Malaysia. Asian Pac. J. Cancer Prev. 2010, 11, 867–873. [Google Scholar]
  35. Sherman, S.M.; Nailer, E.; Minshall, C.; Coombes, R.; Cooper, J.; Redman, E.W.C. Awareness and knowledge of HPV and cervical cancer in female students: A survey (with a cautionary note). J. Obstet. Gynaecol. 2016, 36, 76–80. [Google Scholar] [CrossRef] [Green Version]
  36. Patel, H.; Jeve, Y.B.; Sherman, S.M.; Moss, L.E. Knowledge of human papillomavirus and the human papillomavirus vaccine in European adolescents: A systematic review. Sex Transm. Infect 2016, 92, 474–479. [Google Scholar] [CrossRef]
  37. Samkange-Zeeb, F.; Mikolajczyk, R.T.; Zeeb, H. Awareness and knowledge of sexually transmitted diseases among secondary school students in two German cities. J. Community Health. 2013, 38, 293–300. [Google Scholar] [CrossRef]
  38. Sopracordevole, F.; Cigolot, F.; Gardonio, V. Teenagers’ knowledge about HPV infection and HPV vaccination in the first year of the public vaccination programme. Eur. J. Clin. Microbiol. Infect Dis. 2012, 31, 2319–2325. [Google Scholar] [CrossRef]
  39. Chernyshov, P.V.; Humenna, I. Human papillomavirus: Vaccination, related cancer awareness, and risk of transmission among female medical students. Acta Derm. Alp Pannonica Adriat 2019, 28, 75–79. [Google Scholar] [CrossRef]
  40. Dugandžija, T.; Mikov, M.M.; Rajcevic, S.; Kacavenda, D.; Malenkovic, G.; Ristic, M. Information sources for Serbian women on cervical carcinoma risk factors. Asian. Pac. J. Cancer Prev. 2012, 13, 2931–2934. [Google Scholar] [CrossRef] [Green Version]
  41. Kesic, V.; Markovic, M.; Matejic, B.; Topic, L. Awareness of cervical cancer screening among women in Serbia. Gynecol. Oncol. 2005, 99, S222–S225. [Google Scholar] [CrossRef] [PubMed]
  42. Troha, M.; Šterbenc, A.; Mlaker, M.; Poljak, M. Human papillomavirus (HPV) infection and vaccination: Knowledge and attitudes among healthcare professionals and the general public in Slovenia. Acta Derm. Alp Pannonica Adriat 2018, 27, 59–64. [Google Scholar] [CrossRef]
  43. Unger, Z.; Maitra, A.; Kohn, J.; Devaskar, S.; Stern, L.; Patel, A. Knowledge of HPV and HPV vaccine among women ages 19 to 26. Womens Health Issues 2015, 25, 458–462. [Google Scholar] [CrossRef] [PubMed]
  44. Donati, S.; Giambi, C.; Declich, S.; Salmaso, S.; Filia, A.; degli Atti, M.L.C.; Alibrandi, M.P.; Brezzi, S.; Carozzi, F.; Carozzi, F.; et al. Knowledge, attitude and practice in primary and secondary cervical cancer prevention among young adult Italian women. Vaccine 2012, 30, 2075–2082. [Google Scholar] [CrossRef]
  45. Wen, Y.; Pan, X.F.; Zhao, Z.M.; Chen, F.; Fu, J.C.; Li, Q.S.; Zhao, Y.; Chang, H.; Xue, P.Q.; Yang, X.C. Knowledge of human papillomavirus (HPV) infection, cervical cancer, and HPV vaccine and its correlates among medical students in Southwest China: A multi-center cross-sectional survey. Asian Pac. J. Cancer Prev. 2014, 15, 5773–5779. [Google Scholar] [CrossRef] [Green Version]
Table 1. Socio-demographic characteristics of the participants.
Table 1. Socio-demographic characteristics of the participants.
VariableN(%)
Faculty/college attending
 Medical229(14.2)
 Other1387(85.2)
Type of high school finished
 Grammar school665(41.1)
 Other, non-medical high school709(43.9)
 Medical high school242(15)
Place of residence
 Urban area1224(75.7)
 Rural area392(24.3)
Mother’s level of education a
 Low81(5)
 Middle1000(62)
 High531(33)
Father’s level of education a
 Low47(2.9)
 Middle940(59.1)
 High604(38)
Financial status/income
 Low159(9.8)
 Middle825(51.1)
 High632(39.1)
Marital/relationship status b
 Single890(55.1)
 In relationship726(44.9)
Ever had sexual intercourse
 Yes820(50.7)
 No796(49.3)
Number of sexual partners c
 1526(64.1)
 2–4272(33.2)
 5+ 22(2.7)
a Missing data due to death of a parent; b Other response options were not chosen by our participants; c Of those that had had sexual intercourse; 5+—five and more.
Table 2. Association of participants’ socio-demographic characteristics with cervical cancer knowledge score.
Table 2. Association of participants’ socio-demographic characteristics with cervical cancer knowledge score.
VariableCervical Cancerp
Knowledge Score
Faculty/college attending <0.001
 Medical 21.21 ± 5.73
 Other15.54 ± 7.94
Type of high school finished <0.001
 Grammar school16.79 ± 7.73
 Other, non-medical high school 14.69 ± 7.98 a,b
 Medical high school20.82 ± 6.38 b
Place of residence 0.01
 Urban area 16.62 ± 7.82
 Rural area15.48 ± 8.16
Mother’s level of education <0.001
 Low 13.33 ± 8.27 c,d
 Middle 16.22 ± 8.04
 High17.02 ± 7.53
Father’s level of education 0.006
 Low 15.68 ± 7.82
 Middle 15.78 ± 8.09
 High17.22 ± 7.57 e
Financial status/income 0.008
 Low 14.25 ± 8.53
 Middle 16.62 ± 7.85 f
 High16.51 ± 7.79 f
Marital/relationship status 0.019
 Single 15.89 ± 8.06
 In relationship16.96 ± 7.69
Ever had sexual intercourse 0.065
 Yes 16.67 ± 7.90
 No16.01 ± 7.93
Number of sexual partners g 0.537
 116.65 ± 7.80
 2–416.96 ± 8.08
 5+ 17.00 ± 8.45
a Vs. medical high school, p < 0.05; b vs. grammar school, p < 0.05; c vs. middle educated mother, p < 0.05; d vs. high educated mother, p < 0.05; e vs. middle educated father, p < 0.05, f vs. low income, p < 0.05; g of those that had had sexual intercourse; 5+—five and more.
Table 3. Association of participants’ socio-demographic characteristics with HPV and HPV vaccine awareness.
Table 3. Association of participants’ socio-demographic characteristics with HPV and HPV vaccine awareness.
Heard about HPV N (%)Heard about HPV Vaccine a N (%)Know When the Best Time to Get the HPV Vaccine is b N (%)Know that HPV Vaccine is Available in Serbia b N (%)
Faculty/college attending
Medical 15567.75032.3106.5159.7
Other63345.617928.3274.3335.2
p * <0.0010.3790.2490.037
Type of high school finished
Grammar school 295 **44.48428.5144.7165.4
Other, non-medical high schools 303 **42.77926.1155.0196.3
Medical high school19078.56634.784.2136.8
p *<0.0010.1190.9300.805
Place of residence
Urban area 60349.317228.5294.8386.3
Rural area18547.25730.884.3105.4
p1,* 0.5120.6120.7850.656
Mother’s level of education c
Low 4353.16 ***14.012.300.0
Middle 47547.513828.8204.2265.5
High26850.58531.7166.0228.2
p *0.3940.0410.4150.074
Father’s level of education c
Low 2042.6840.015.015.0
Middle 46649.613328.5183.9265.6
High29548.88629.2186.1206.8
p *0.6340.5610.3660.780
Financial status/income
Low7345.92230.145.534.1
Middle 3884711028.4184.6318.0
High32757.19729.7154.6144.3
p *0.1530.9080.9460.090
Marital/relationship status
Single 40645.610525.9143.4204.9
In relationship38252.612432.5236.0287.3
p *0.0050.0410.0880.159
Ever had sexual intercourse
Yes 43553.014834.0214.8317.1
No35344.38122.9164.5174.8
p1,*0.0010.0010.8460.177
Number of sexual partners d
1 27452.19735.4155.5196.9
2–4 14954.84530.242.7117.4
5+ 1254.5650.0216.718.3
p *0.7630.2850.0670.972
* Chi-squared test; ** vs. medical high school, p < 0.05; *** vs. high educated mother, p < 0.05; a only those that had also heard about HPV were taken into account; b only those that had heard about HPV and the HPV vaccine were taken into account; c missing data due to death of a parent; d of those that had had sexual intercourse; 1—not significant; 5+—five and more; Human papillomavirus—HPV.
Table 4. Source of information and its association with cervical cancer knowledge score, HPV and HPV vaccine awareness.
Table 4. Source of information and its association with cervical cancer knowledge score, HPV and HPV vaccine awareness.
Source of InformationKnowledge Score about Cervical CancerHeard about HPVHeard about HPV Vaccine aKnow the Best Time to Get the HPV Vaccine bKnow that HPV Vaccine is Available in Serbia b
NN(%)N(%)N(%)N(%)
Media
Yes17.38 ± 7.5253267.515869.02978.43470.8
No14.62 ± 8.2825632.57131.0821.61429.2
p<0.001 *<0.001 ***0.628 ***0.249 ***0.893 ***
OHEc
Yes18.49 ± 7.1551265.017074.23389.24287.5
No13.87 ± 8.0527635.05925.8410.8612.5
p<0.001 *<0.001 ***<0.001 ***0.039 ***0.029 ***
Personal contact
Yes18.42 ± 6.9829837.89441.01745.92041.7
No15.31 ± 8.1649062.213559.02054.12858.3
p<0.001 **<0.001 ***0.264 ***0.632 ***0.922 ***
* Mann–Whitney test; ** independent t-test; *** chi-squared test; a Only those who had also heard about HPV were taken into account; b Only those who had heard about HPV and the HPV vaccine were taken into account; c OHE—organized health education.

Share and Cite

MDPI and ACS Style

Rančić, N.K.; Golubović, M.B.; Ilić, M.V.; Ignjatović, A.S.; Živadinović, R.M.; Đenić, S.N.; Momčilović, S.D.; Kocić, B.N.; Milošević, Z.G.; Otašević, S.A. Knowledge about Cervical Cancer and Awareness of Human Papillomavirus (HPV) and HPV Vaccine among Female Students from Serbia. Medicina 2020, 56, 406. https://doi.org/10.3390/medicina56080406

AMA Style

Rančić NK, Golubović MB, Ilić MV, Ignjatović AS, Živadinović RM, Đenić SN, Momčilović SD, Kocić BN, Milošević ZG, Otašević SA. Knowledge about Cervical Cancer and Awareness of Human Papillomavirus (HPV) and HPV Vaccine among Female Students from Serbia. Medicina. 2020; 56(8):406. https://doi.org/10.3390/medicina56080406

Chicago/Turabian Style

Rančić, Nataša K., Milan B. Golubović, Mirko V. Ilić, Aleksanda S. Ignjatović, Radomir M. Živadinović, Saša N. Đenić, Stefan D. Momčilović, Biljana N. Kocić, Zoran G. Milošević, and Suzana A. Otašević. 2020. "Knowledge about Cervical Cancer and Awareness of Human Papillomavirus (HPV) and HPV Vaccine among Female Students from Serbia" Medicina 56, no. 8: 406. https://doi.org/10.3390/medicina56080406

Article Metrics

Back to TopTop